4//SEC Filing
MOORE ALISON 4
Accession 0001415889-25-018279
CIK 0001817241other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:30 PM ET
Size
5.4 KB
Accession
0001415889-25-018279
Insider Transaction Report
Form 4
MOORE ALISON
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-24+13,750→ 13,750 totalExercise: $1.61Exp: 2035-06-23→ Common Stock (13,750 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the earlier of June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting.
Documents
Issuer
Artiva Biotherapeutics, Inc.
CIK 0001817241
Entity typeother
Related Parties
1- filerCIK 0001754937
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:30 PM ET
- Size
- 5.4 KB